Association between Albumin Administration and Pulmonary Complications in Patients with Septic Shock: An Analysis...

Area of Science:

• Critical Care Medicine
• Pulmonary Medicine
• Pharmacology

Background:

• Septic shock management often involves albumin, but its pulmonary effects are debated.
• Pulmonary complications, particularly acute respiratory distress syndrome (ARDS), are a concern in septic shock patients.

Purpose of the Study:

• To investigate the association between albumin administration and the development of ARDS in adult patients with septic shock.
• To determine if albumin use impacts ARDS incidence within 7 days of septic shock diagnosis.

Main Methods:

• Retrospective analysis of adult septic shock patients from the MIMIC-IV database.
• Propensity score matching to create comparable albumin and non-albumin groups.
• Kaplan-Meier survival analysis and subgroup analyses to assess ARDS development rates.

Main Results:

• No significant difference in moderate-to-severe ARDS development was observed between patients who received albumin (17.5%) and those who did not (16.3%), P=0.708.
• Kaplan-Meier curves showed similar ARDS development trajectories in both groups.
• Subgroup analyses did not reveal any increased ARDS risk associated with albumin administration across different patient strata.

Conclusions:

• Albumin administration in septic shock patients is not associated with a higher incidence of acute respiratory distress syndrome.
• Clinicians may consider albumin for septic shock patients based on clinical indications, without significant apprehension regarding ARDS development.